Northeast Financial Consultants Inc Increases Stake in Zoetis Inc (NYSE:ZTS)

Northeast Financial Consultants Inc increased its holdings in Zoetis Inc (NYSE:ZTS) by 26.4% in the first quarter, HoldingsChannel reports. The firm owned 20,432 shares of the company’s stock after acquiring an additional 4,262 shares during the period. Northeast Financial Consultants Inc’s holdings in Zoetis were worth $2,057,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Farmers & Merchants Trust Co of Chambersburg PA purchased a new stake in Zoetis during the 1st quarter valued at $25,000. Glassman Wealth Services boosted its position in Zoetis by 306.5% during the 1st quarter. Glassman Wealth Services now owns 252 shares of the company’s stock valued at $25,000 after buying an additional 190 shares during the period. Berman Capital Advisors LLC purchased a new stake in Zoetis during the 4th quarter valued at $26,000. Private Ocean LLC purchased a new stake in Zoetis during the 1st quarter valued at $27,000. Finally, Athena Capital Advisors LLC purchased a new stake in Zoetis during the 4th quarter valued at $29,000. 90.30% of the stock is owned by institutional investors.

Several equities research analysts have weighed in on ZTS shares. BMO Capital Markets increased their price target on shares of Zoetis from $101.00 to $105.00 and gave the company a “market perform” rating in a research report on Thursday, May 9th. Credit Suisse Group increased their price target on shares of Zoetis from $102.00 to $112.00 and gave the company an “outperform” rating in a research report on Tuesday, April 2nd. Zacks Investment Research upgraded shares of Zoetis from a “sell” rating to a “hold” rating in a report on Saturday, February 16th. Stifel Nicolaus upgraded shares of Zoetis from a “hold” rating to a “buy” rating and upped their price objective for the stock from $97.00 to $110.00 in a report on Monday, March 4th. Finally, SunTrust Banks assumed coverage on shares of Zoetis in a report on Tuesday, March 19th. They issued a “hold” rating and a $100.00 price objective for the company. Six analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Zoetis presently has an average rating of “Buy” and an average price target of $105.00.

Shares of Zoetis stock traded up $1.29 during trading on Wednesday, hitting $111.45. The company’s stock had a trading volume of 1,010,743 shares, compared to its average volume of 2,247,393. The company has a debt-to-equity ratio of 2.84, a current ratio of 4.05 and a quick ratio of 2.79. The firm has a market cap of $52.68 billion, a price-to-earnings ratio of 35.61, a PEG ratio of 2.75 and a beta of 0.87. Zoetis Inc has a 52 week low of $78.90 and a 52 week high of $111.66.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Thursday, May 2nd. The company reported $0.88 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.79 by $0.09. The company had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.45 billion. Zoetis had a net margin of 23.47% and a return on equity of 73.66%. Zoetis’s quarterly revenue was up 6.5% compared to the same quarter last year. During the same period last year, the business earned $0.75 EPS. On average, equities analysts anticipate that Zoetis Inc will post 3.48 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 3rd. Investors of record on Friday, July 19th will be paid a $0.164 dividend. The ex-dividend date is Thursday, July 18th. This represents a $0.66 annualized dividend and a dividend yield of 0.59%. Zoetis’s payout ratio is 21.09%.

In other Zoetis news, insider Clinton A. Jr. Lewis sold 6,125 shares of the firm’s stock in a transaction dated Thursday, March 14th. The shares were sold at an average price of $96.54, for a total transaction of $591,307.50. Following the completion of the sale, the insider now directly owns 57,042 shares in the company, valued at approximately $5,506,834.68. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Clinton A. Jr. Lewis sold 6,124 shares of the firm’s stock in a transaction dated Monday, April 15th. The shares were sold at an average price of $101.60, for a total transaction of $622,198.40. Following the sale, the executive vice president now owns 54,484 shares of the company’s stock, valued at $5,535,574.40. The disclosure for this sale can be found here. Over the last quarter, insiders sold 76,716 shares of company stock valued at $7,805,856. 0.29% of the stock is owned by company insiders.

COPYRIGHT VIOLATION NOTICE: This news story was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US & international trademark and copyright law. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2019/06/12/northeast-financial-consultants-inc-increases-stake-in-zoetis-inc-nysezts.html.

Zoetis Profile

Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

Recommended Story: What is the Coverage Ratio?

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.